This is an observational COVID-19 study that uses wearable health monitoring technology to follow COVID-19 positive individuals to monitor persistent symptoms and any potential long-term complications or cardiovascular and behavioral impacts from the disease.
Participants will wear a Biostrap wristband device that captures high-fidelity, raw photoplethysmography (PPG) waveforms and collects important indicators of heart and mental health, including heart rate, heart rate variability, pulse points, oxygen saturation and sleep patterns. Biometric data will be collected and participants will be alerted if any measurements are outside their normal range. Researchers are recruiting 200 participants who were diagnosed with COVID-19.
Study Type
OBSERVATIONAL
Enrollment
200
Tulane University, TRIAD Center
New Orleans, Louisiana, United States
Tulane University
New Orleans, Louisiana, United States
Incidence of major cardiovascular events
Including arrhythmia occurrence or recurrence, congestive heart failure, myocardial infarction, cardiomyopathy and ischemic stroke.
Time frame: 12 Months
Incidence of atrial arrhythmia
Including atrial fibrillation, atrial flutter, atrial tachycardia
Time frame: 12 Months
Mental health effect of COVID-19 measured by incidence of Generalized Anxiety Disorder (GAD) using Generalized Anxiety Disorder 7-item (GAD-7) Scale
Generalized Anxiety Disorder 7-item (GAD-7) Scale includes 7 questions to be answered by the patient, each answer is scored from 0 to 3, and the scale range is from 0 to 21, with a higher number representing more severe GAD level
Time frame: 12 Months
Mental health effect of COVID-19 measured by incidence of depression using Beck Depression Fast Screen Scale
Beck Depression Fast Screen Scale includes 21 questions to be answered by the patient scored from 0 to 3, and the scale range is from 0 to above 40, with a higher number representing more severe depression level
Time frame: 12 Months
Mental health effect of COVID-19 measured by incidence of Post Traumatic Stress Syndrome (PTSD) using the Post Traumatic Stress Disorder Checklist- Standard Form (PCL-S) scale
Post Traumatic Stress Disorder Checklist- Standard Form (PCL-S) Scale includes 20 questions to be answered by the patient scored from 1 to 5. Total symptom severity score (ranging 0-80) can be obtained by summing the scores for each of the 20 items. Higher number represents more likely that the patient has PTSD.
Time frame: 12 Months
Mental health effect of COVID-19 measured by incidence of substance abuse using a baseline use of alcohol survey
Baseline use of alcohol survey includes ten questions to be answered by the patient scored from 0 to 4 with a higher number representing increased alcohol consumption
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 12 Months
Mental health effect of COVID-19 measured by incidence of substance abuse using a baseline use of drugs survey
Baseline use of drugs survey includes ten questions to be answered by the patient scored from 0 to 4 with a higher number representing increased drug use
Time frame: 12 Months
Mental health effect of COVID-19 measured by incidence of substance abuse using a baseline use of nicotine products survey
Baseline use of nicotine products survey includes 4 questions to be answered by the patient to find out which nicotine products the patient is using if any and how many cigarettes they're smoking per day
Time frame: 12 Months